Formosa Laboratories Inc
TWSE:4746
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Hangzhou Zhongya Machinery Co Ltd
SZSE:300512
|
CN |
Formosa Laboratories Inc
Capital Expenditures
Formosa Laboratories Inc
Capital Expenditures Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Capital Expenditures | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Formosa Laboratories Inc
TWSE:4746
|
Capital Expenditures
-NT$843.1m
|
CAGR 3-Years
-24%
|
CAGR 5-Years
4%
|
CAGR 10-Years
-8%
|
|
|
Y
|
YungShin Global Holding Corp
TWSE:3705
|
Capital Expenditures
-NT$492.9m
|
CAGR 3-Years
-34%
|
CAGR 5-Years
-13%
|
CAGR 10-Years
-3%
|
|
|
ScinoPharm Taiwan Ltd
TWSE:1789
|
Capital Expenditures
-NT$291.3m
|
CAGR 3-Years
-6%
|
CAGR 5-Years
-10%
|
CAGR 10-Years
8%
|
|
|
Lotus Pharmaceutical Co Ltd
TWSE:1795
|
Capital Expenditures
-NT$4.4B
|
CAGR 3-Years
-12%
|
CAGR 5-Years
-17%
|
CAGR 10-Years
-24%
|
|
|
Standard Chem & Pharm Co Ltd
TWSE:1720
|
Capital Expenditures
-NT$506.9m
|
CAGR 3-Years
25%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
-11%
|
|
|
C
|
Caliway Biopharmaceuticals Co Ltd
TWSE:6919
|
Capital Expenditures
-NT$17.1m
|
CAGR 3-Years
-7%
|
CAGR 5-Years
-49%
|
CAGR 10-Years
N/A
|
|
Formosa Laboratories Inc
Glance View
Formosa Laboratories, Inc. engages in the research and development of biotechnology new drugs. The company is headquartered in Taoyuan, Taoyuan. The company went IPO on 2009-11-27. The firm primarily provides UV-proof active ingredients series products, vitamin D derivative series products, anti-inflammatory analgesic series products, steroid, anti-cancer drugs, cholesterol phosphate binding agents, nuclear magnetic resonance (NMR) reagents, respiratory disease drugs, central nervous system drugs, immune system regulators and weight loss drugs, as well as customized research and development and original equipment manufacturing (OEM) services. The firm distributes its products to Europe, the Americas, Asia and other markets.
See Also
What is Formosa Laboratories Inc's Capital Expenditures?
Capital Expenditures
-843.1m
TWD
Based on the financial report for Dec 31, 2025, Formosa Laboratories Inc's Capital Expenditures amounts to -843.1m TWD.
What is Formosa Laboratories Inc's Capital Expenditures growth rate?
Capital Expenditures CAGR 10Y
-8%
Over the last year, the Capital Expenditures growth was -43%. The average annual Capital Expenditures growth rates for Formosa Laboratories Inc have been -24% over the past three years , 4% over the past five years , and -8% over the past ten years .
